Colorado's Leading Retina Education Event For Eye Care Providers
Sunday, February 23, 2025 from 8:00 AM - 12:30pm MT
CE Credit: Pending Approval- 4 hours AMA PRA Category 1 Credit™ and 4 hours COPE CE Credit
Venue: Social Capitol - 6543 Wadsworth Blvd, Arvada, CO 80003
Virtual and in-person attendance options- REGISTER TODAY BEFORE PRICES GO UP!
Presented by Colorado Retina Associates, our half-day meeting offers eye care providers an invaluable opportunity to expand their knowledge of retinal diseases, sharpen their clinical skills, and enhance patient care.
Mile High Masters of Retina features a dynamic mix of rapid fire lectures, expert panels and debates, and case presentations, covering both common and complex retinal conditions. Attendees will gain diagnostic tips, treatment approaches, and practical pearls to apply in their daily practice.
Agenda
7:00 - 8:00 AM ~ REGISTRATION AND BREAKFAST
8:00 – 10:05 AM ~ SESSION 1
Photobiomodulation and the Retina Salil Shukla, MD
Discussion of how photobiomodulation works in regards to macular disease, clinical trial data, and new FDA approved treatment modalities.
Episcleral Plaque Brachytherapy Peter G. Hovland, MD, PhD
Indications and Surgical Technique of Episcleral Plaque Brachytherapy will be presented
Panel Discussion: The Utilization of Lasers in Retinal Care Robert Courtney, MD, Mimi Liu, MD, Miriah Teeter, MD
Lasers have been a part of retinal care since the 1940s. While individual treatment preferences can differ among retinal physicians, many guiding principles shape the modern retinal physician practice patterns. In this panel we will discuss the utilization of lasers in the treatment of retinal breaks, vascular conditions, floaters and the considerations of using laser in each of these cases.
Clinical Trial Updates: Cutting Edge in Retinal Care Murtaza Adam, MD
Highlighting the clinical trials that Colorado Retina has contributed to and will review pivotal clinical trial results that could make a significant impact on patient care.
Complement Inhibition for Geographic Atrophy Ashleigh Levison, MD + Miriah Teeter, MD
The era of treating geographic atrophy in advanced age-related macular degeneration with complement inhibition began last year with the approval of two medications in this novel category. Complement inhibition has been shown to slow the progression of GA significantly. Undergoing treatment is a substantial commitment and involves some degree of risk. Our understanding of these treatments and their clinical application continues to grow and evolve.
9:10 - 10:05 AM ~ KEYNOTE- Debunking Ophthalmic Misinformation
Timothy Caulfield- Professor of Health Law and Science Policy | Bestselling Author
10:05 - 10:35 AM ~ EXHIBIT AND SNACK BREAK
10:35 AM - 12:30 PM ~ SESSION 2
Panel: Uveitis Q&A Ashleigh Levison, MD, Andrew Zheng, MD, Vlad Matei, MD
Uveitis can be a daunting ocular condition to face in clinic, often requiring complex systemic co-management with rheumatology. CRA’s three uveitis physicians will discuss questions from our referring community on how to approach uveitis treatment in general practice, when a referral is necessary for your patient, immunomodulatory therapy, and more.
The Anti-Bacterial Battalion: Updates on Endophthalmitis Mitigation and Treatment Murtaza Adam, MD
Review data and approaches pioneered by Colorado Retina physicians to mitigate and treat post-procedural endophthalmitis.
Pros and Cons of Pneumatic Retinopexy Vlad Matei, MD + Andrew Zheng, MD
Pneumatic retinopexy is a minimally invasive technique for fixing retinal detachments. This technique can prevent a trip to the operating room for select retinal detachment patients and has been shown to have improved visual outcomes in some patients. However, not all retinal detachment patients are good candidates for pneumatic retinopexy. The success of the procedure also depends heavily on the patient’s ability to cooperate and position during the post-procedural period. If failed, additional surgical intervention is required. Treatment of choice is up to the discretion and preference of the treating physician.
Late-onset Stargardt Disease Peter G. Hovland, MD, PhD
Late onset Stargardt Disease may resemble ARMD. Genetic evaluation is helpful to distinguishthese disease entities
Conceiving the Consequences: A Cautionary Tale Rebecca Nelson, CGC
A patient's genetic test results impact her sister's choices.
Panel: Drug Selection Paradigm in Retinal Treatments Mimi Liu, MD, Frank Siringo, MD, OD, Robert Courtney, MD
The landscape of retinal treatments is expanding swiftly with biosimilars, new drug delivery modalities, and medications available for conditions that were previously untreatable. Get inside a retina specialists head to understand in this era of growing options, how do they make decisions for treatments for your patients?
Ocular Considerations of Ozempic Brian Joondeph, MD
Ozempic represents a new and popular drug for managing Type 2 diabetes and weight loss in non-diabetic patients. There are ocular and systemic side effects and implications. These will be reviewed with recommendations for eye care providers in managing patients on these new classes of drugs
Debate: Vitrectomy vs Scleral Buckle for Retinal Detachment Repair Frank Siringo, MD, OD + Curtis Hagedorn, MD
Pros and cons of vitrectomy and scleral buckle approaches to retinal detachment repair will be discussed in a debate format.
Accrediation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC and Colorado Retina Associates. Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians.
Evolve Medical Education, LLC designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented with the accrediation requirements and policies of the Association of Regulatory Boards of Optometry, Inc. (ARBO) through The Council on Optometric Practitioner Education (COPE), a nationally recognized accreditation program for optometric continuing education (CE) courses. COPE CE offered, pending board approval.
MHMR Sponsorship Opportunities
For sponsors, this event offers a unique marketing platform to showcase your support, products, and services to Colorado's eye care community. Benefits may include: targeted exposure, brand recognition, networking education and lead generation. Exhibit booth space is limited, complete the Sponsorship Application to secure your spot!
